Mirae Asset Life Launches Healthcare Cancer Insurance Covering Prevention to Treatment

Mirae Asset Life Insurance announced on the 3rd that it has launched the 'Healthcare Cancer Insurance,' which provides coverage from cancer prevention to treatment and convalescence.

[Asia Economy Reporter Oh Hyung-gil] Mirae Asset Life Insurance announced on the 3rd that it has launched the 'Healthcare Cancer Insurance,' which provides coverage from cancer prevention to treatment and recuperation.

By utilizing the main contract and riders, it is possible to subscribe to a high amount of diagnosis insurance money to ensure sufficient coverage for cancer. Through the main insurance, coverage for breast cancer and prostate cancer, which have been increasing recently, is provided at the same level as general cancer.

Using riders, thyroid cancer, which is generally covered with a small amount, can be insured for up to 30 million KRW, and carcinoma in situ, borderline tumors, and other similar cancers can be insured for up to 20 million KRW in diagnosis insurance money. Targeted anticancer drug treatment, which has fewer side effects but high treatment costs, can be covered up to 60 million KRW through additional riders.

Additionally, riders are available that cover diagnostic funds related to heart and cerebrovascular diseases, as well as various surgeries and hospitalization.

To support cancer prevention activities, discounts are offered to non-smokers and women vaccinated against cervical cancer (HPV). The insurance also includes a rider for discounted premiums for women with multiple childbirths, which recently obtained exclusive usage rights, allowing these women to subscribe with greater benefits.

There are also optional riders related to re-diagnosis considering the possibility of recurrence after cancer treatment, and a rider that supports up to 100 housekeeping assistance sessions.

The reduction period has also been eliminated. In the case of the main insurance, 100% of the subscribed amount can be received immediately after the waiting period (90 days after subscription), and similar cancers are covered from the first day.

Oh Eun-sang, Head of Product Development at Mirae Asset Life Insurance, stated, "We designed this product so that customers can choose the coverage they need in all aspects, from cancer prevention to the prodromal stage, treatment, and recuperation," adding, "It will be the best choice for customers who want sufficient coverage for cancer or want to supplement insufficient coverage."